To date, it is known that EGFR endocytosis and cytoprotective autophagy triggered by TKI treatment serve as bypass drug-resistant mechanisms in cancer cells; however, the underlying mechanism remains a mystery (59, 74, 75, 76). The gene discussed is EGFR; the disease is cancer.